CXCL13 is a key homeostatic chemokine constitutively expressed in lymphoid organs and also induced upon CNS inflammation, serving as a biomarker for Lyme neuroborreliosis (LNB), CNS lymphoma, and multiple sclerosis (MS) (39). This evidence concerns the gene CXCL13 and myeloid sarcoma.